May 28, 2009Journal of Translational Medicine123 citationsOpen Access

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

HCHye Won ChungYonsei University SLSang‐Guk LeeYonsei University HKHeejung KimSeoul National University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

HMGB1 appears to be a useful serological biomarker for early diagnosis as well as evaluating the tumorigenesis, stage, and prognosis of gastric cancer.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Chung et al. (Thu,) studied this question.

synapsesocial.com/papers/69d77c565f9a1dad53490575 https://doi.org/https://doi.org/10.1186/1479-5876-7-38

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1HMG-1 as a Late Mediator of Endotoxin Lethality in Mice1999 · 3,410 citations
2Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.1990 · 1,143 citations
3Evaluation of the new international union against cancer TNM staging for gastric carcinoma2000 · 103 citations
4Variation of HMGB1 expression in breast cancer.2002 · 77 citations
5Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.2004 · 79 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo